Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SOWAHC pseudogene 2 (SOWAHCP2) is a genomic pseudogene, meaning it is a DNA sequence derived from the SOWAHC gene but is non-functional and generally does not encode a protein[5][7]. While some pseudogenes can produce long non-coding RNAs and may regulate gene expression, there is no evidence of canonical biological activity, disease relevance, or therapeutic targeting for SOWAHCP2[6][8]. It is not considered a receptor, enzyme, transporter, or therapeutic target. The term “pseudogene” precisely denotes a genetic locus with sequence similarity to a functional gene, yet without demonstrated protein-coding capability or established biological effect. As a pseudogene, SOWAHCP2 is not a protein-coding gene and is not considered a canonical drug target or receptor. There are no established aliases, functions, disease roles, or interactions for SOWAHCP2. If the intended focus was a protein-coding target, SOWAHC (not SOWAHCP2) is relevant as a protein-coding gene with possible biomarker value[1][2]. This entry for SOWAHCP2 should be flagged as incorrect for therapeutic target analysis.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SOWAHC pseudogene 2 (SOWAHCP2).